Quanterix Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 136

Employees

  • Stock Symbol
  • QTRX

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $5.60
  • (As of Thursday Closing)

Quanterix General Information

Description

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Contact Information

Formerly Known As
Digital Genomics
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 900 Middlesex Turnpike
  • Building 1
  • Billerica, MA 01821
  • United States
+1 (617)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 900 Middlesex Turnpike
  • Building 1
  • Billerica, MA 01821
  • United States
+1 (617)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quanterix Stock Performance

As of 24-Apr-2025, Quanterix’s stock price is $5.60. Its current market cap is $217M with 38.8M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.60 $5.34 $4.67 - $19.18 $217M 38.8M 748K -$1.00

Quanterix Financials Summary

As of 31-Dec-2024, Quanterix has a trailing 12-month revenue of $135M.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 154,482 154,482 748,954 212,428
Revenue 135,436 135,436 121,139 104,952
EBITDA (44,396) (44,396) (35,184) (98,417)
Net Income (38,531) (38,531) (28,354) (99,574)
Total Assets 406,533 406,533 428,567 433,582
Total Debt 37,371 37,371 41,464 44,104
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Quanterix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Quanterix‘s full profile, request access.

Request a free trial

Quanterix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform tha
Diagnostic Equipment
Billerica, MA
136 As of 2024

Forchheim, Germany
 

Sunnyvale, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quanterix Competitors (13)

One of Quanterix’s 13 competitors is Siemens Healthineers, a Corporation company based in Forchheim, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Siemens Healthineers Corporation Forchheim, Germany
Cepheid Formerly VC-backed Sunnyvale, CA
T2 Biosystems Formerly VC-backed Lexington, MA
Chembio Diagnostic Corporate Backed or Acquired Medford, NY
Accelerate Diagnostics Corporation Tucson, AZ
You’re viewing 5 of 13 competitors. Get the full list »

Quanterix Patents

Quanterix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220205992-A1 Materials and kits relating to association of reporter species and targeting entities with beads Inactive 28-Dec-2020
US-20220050106-A1 Methods and kits for detecting sars-coronavirus-2 antigen Pending 14-Aug-2020
US-20210341479-A1 Quantitative antibody test Active 30-Apr-2020
US-11686730-B2 Quantitative antibody test Active 30-Apr-2020
EP-4135897-A2 Methods and systems related to highly sensitive, digital assays by improved delivery of capture objects Pending 15-Apr-2020 G01N33/54386
To view Quanterix’s complete patent history, request access »

Quanterix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quanterix Acquisitions (4)

Quanterix’s most recent deal was a Merger/Acquisition with Akoya Biosciences. The deal was made on 10-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Akoya Biosciences 10-Jan-2025 Merger/Acquisition Other Healthcare Technology Systems
Emission 08-Jan-2025 Merger/Acquisition Other Commercial Products
UmanDiagnostics 01-Aug-2019 Merger/Acquisition Diagnostic Equipment
Aushon BioSystems 30-Jan-2018 Merger/Acquisition Discovery Tools (Healthcare)
To view Quanterix’s complete acquisitions history, request access »

Quanterix ESG

Risk Overview

Risk Rating

Updated October, 15, 2024

25.43 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,109

Rank

Percentile

Pharmaceuticals

Industry

of 861

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 60

Rank

Percentile

To view Quanterix’s complete esg history, request access »

Quanterix Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Emission Georgetown, TX 2020
UmanDiagnostics Umea, Sweden 2006

Quanterix FAQs

  • When was Quanterix founded?

    Quanterix was founded in 2007.

  • Where is Quanterix headquartered?

    Quanterix is headquartered in Billerica, MA.

  • What is the size of Quanterix?

    Quanterix has 136 total employees.

  • What industry is Quanterix in?

    Quanterix’s primary industry is Diagnostic Equipment.

  • Is Quanterix a private or public company?

    Quanterix is a Public company.

  • What is Quanterix’s stock symbol?

    The ticker symbol for Quanterix is QTRX.

  • What is the current stock price of Quanterix?

    As of 24-Apr-2025 the stock price of Quanterix is $5.60.

  • What is the current market cap of Quanterix?

    The current market capitalization of Quanterix is $217M.

  • What is Quanterix’s current revenue?

    The trailing twelve month revenue for Quanterix is $135M.

  • Who are Quanterix’s competitors?

    Siemens Healthineers, Cepheid, T2 Biosystems, Chembio Diagnostic, and Accelerate Diagnostics are some of the 13 competitors of Quanterix.

  • What is Quanterix’s annual earnings per share (EPS)?

    Quanterix’s EPS for 12 months was -$1.00.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »